Market Cap | 11.35B | P/E | 16.60 | EPS this Y | - | Ern Qtrly Grth | -47.10% |
Income | 504.94M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | 8.39B | PEG | - | EPS past 5Y | - | 200D Avg Chg | 6.00% |
Dividend | 4.00% | Price/Book | 1.50 | EPS next 5Y | - | 52W High Chg | -7.00% |
Recommedations | - | Quick Ratio | 0.78 | Shares Outstanding | 480.40M | 52W Low Chg | 29.00% |
Insider Own | 4.88% | ROA | 3.83% | Shares Float | 454.50M | Beta | 0.49 |
Inst Own | 38.53% | ROE | 6.91% | Shares Shorted/Prior | -/- | Price | 23.73 |
Gross Margin | 33.00% | Profit Margin | 6.02% | Avg. Volume | 379 | Target Price | - |
Oper. Margin | 8.49% | Earnings Date | - | Volume | 89 | Change | 0.00% |
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.